A detailed history of Bristol Gate Capital Partners Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Bristol Gate Capital Partners Inc. holds 472,602 shares of ZTS stock, worth $82.9 Million. This represents 3.76% of its overall portfolio holdings.

Number of Shares
472,602
Previous 473,309 0.15%
Holding current value
$82.9 Million
Previous $93.4 Million 14.4%
% of portfolio
3.76%
Previous 4.66%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$165.67 - $199.94 $117,128 - $141,357
-707 Reduced 0.15%
472,602 $80 Million
Q4 2023

Feb 12, 2024

SELL
$151.44 - $200.09 $2.28 Million - $3.01 Million
-15,054 Reduced 3.08%
473,309 $93.4 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $2.54 Million - $2.93 Million
-15,213 Reduced 3.02%
488,363 $85 Million
Q2 2023

Aug 10, 2023

SELL
$160.94 - $186.23 $1.33 Million - $1.54 Million
-8,285 Reduced 1.62%
503,576 $86.7 Million
Q1 2023

May 10, 2023

SELL
$145.48 - $175.02 $4.28 Million - $5.14 Million
-29,395 Reduced 5.43%
511,861 $85.2 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $6.2 Million - $7.44 Million
47,253 Added 9.57%
541,256 $79.3 Million
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $2.21 Million - $2.72 Million
-14,921 Reduced 2.93%
494,003 $73.3 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $1.2 Million - $1.54 Million
-7,701 Reduced 1.49%
508,924 $87.5 Million
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $3.5 Million - $4.51 Million
19,276 Added 3.88%
516,625 $97.4 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $6.26 Million - $7.99 Million
-32,342 Reduced 6.11%
497,349 $121 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $2.42 Million - $2.68 Million
12,782 Added 2.47%
529,691 $103 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $12.9 Million - $15.5 Million
82,635 Added 19.03%
516,909 $96.3 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $7.29 Million - $8.57 Million
50,591 Added 13.19%
434,274 $68.4 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $2.54 Million - $2.82 Million
16,196 Added 4.41%
383,683 $63.5 Million
Q3 2020

Nov 09, 2020

SELL
$137.1 - $165.37 $3.14 Million - $3.79 Million
-22,917 Reduced 5.87%
367,487 $60.8 Million
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $211,640 - $269,524
-1,891 Reduced 0.48%
390,404 $53.5 Million
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $1.83 Million - $2.86 Million
19,746 Added 5.3%
392,295 $46.2 Million
Q4 2019

Feb 13, 2020

BUY
$116.25 - $133.25 $6.83 Million - $7.82 Million
58,715 Added 18.71%
372,549 $49.3 Million
Q3 2019

Nov 12, 2019

SELL
$112.57 - $128.43 $3.29 Million - $3.75 Million
-29,197 Reduced 8.51%
313,834 $39.1 Million
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $2.41 Million - $2.81 Million
-24,580 Reduced 6.69%
343,031 $38.9 Million
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $30 Million - $37 Million
367,611 New
367,611 $37 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bristol Gate Capital Partners Inc. Portfolio

Follow Bristol Gate Capital Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristol Gate Capital Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bristol Gate Capital Partners Inc. with notifications on news.